149 related articles for article (PubMed ID: 3334055)
1. Calcium antagonists and the kidney.
Chellingsworth M; Kendall MJ
J Hum Hypertens; 1987 Jun; 1(1):3-8. PubMed ID: 3334055
[TBL] [Abstract][Full Text] [Related]
2. The effects of calcium antagonists on electrolytes and water balance in hypertensive patients.
Leonetti G
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S25-9. PubMed ID: 7603074
[TBL] [Abstract][Full Text] [Related]
3. Renal actions of calcium antagonists.
Sterzel RB
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S17-22. PubMed ID: 2455125
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
Rodicio JL
Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium antagonists on renal hemodynamics.
Epstein M; Loutzenhiser RD
Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):10-4. PubMed ID: 2220795
[TBL] [Abstract][Full Text] [Related]
6. An intracellular calcium release inhibitor TMB-8 suppresses renal nerve stimulation-induced antinatriuresis in dogs.
Ogasawara A; Hisa H; Satoh S
J Pharmacol Exp Ther; 1993 Jan; 264(1):117-21. PubMed ID: 8423524
[TBL] [Abstract][Full Text] [Related]
7. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists and renal failure progression.
Robles NR
Ren Fail; 2008; 30(3):247-55. PubMed ID: 18350443
[TBL] [Abstract][Full Text] [Related]
9. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
10. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
[TBL] [Abstract][Full Text] [Related]
11. Functional role of endogenous adenosine in human chronic renal disease.
Balakrishnan VS; Coles GA; Williams JD
Exp Nephrol; 1996; 4(1):26-36. PubMed ID: 8788597
[TBL] [Abstract][Full Text] [Related]
12. Renal actions of calcium channel antagonists.
Osswald H; Weinheimer G; Kapp JF
J Neural Transm Suppl; 1990; 31():39-53. PubMed ID: 2074437
[TBL] [Abstract][Full Text] [Related]
13. Calcium antagonists and the kidney: implications for renal protection.
Epstein M
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S64-70. PubMed ID: 1725007
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of iloprost on blood pressure, heart rate, renal hemodynamics, diuresis, natriuresis, plasma renin activity and plasma norepinephrine in uninephrectomized hypertensive mongrel dogs.
Villa E; Morales ME; Martinez J; de la Fuente A; Hurtado A; Santirso RA; Ruilope LM; Sancho JM; García-Robles R
J Hypertens Suppl; 1991 Dec; 9(6):S352-3. PubMed ID: 1726369
[No Abstract] [Full Text] [Related]
15. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
Zanchi A; Brunner HR; Waeber B; Burnier M
J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
[TBL] [Abstract][Full Text] [Related]
16. Calcium antagonists and the kidney.
Epstein M
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073
[TBL] [Abstract][Full Text] [Related]
17. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
Greven J
Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of nitrendipine monotherapy in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium channel blockade on adrenergically induced renal vasoconstriction in rat models of renal impairment.
Khan AH; Sattar MA; Abdullah NA; Johns EJ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):501-8. PubMed ID: 19673932
[TBL] [Abstract][Full Text] [Related]
20. [Renal protective effects of calcium antagonists].
Musialik D; Raszeja-Wanic B; Tylarski A
Pol Merkur Lekarski; 1996 Oct; 1(4):266-70. PubMed ID: 9156942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
